What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Cancer research, Lung cancer, Surgery, Tumor suppressor gene and Apoptosis.
His Cancer research research is multidisciplinary, incorporating elements of Cell culture, Cell growth, Viral vector, Genetic enhancement and In vivo.
His Lung cancer study which covers Mutation that intersects with Exon.
The concepts of his Surgery study are interwoven with issues in Respiratory disease and Cancer.
His Apoptosis research includes themes of Molecular biology, Downregulation and upregulation and Cell biology.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Oncology.
His most cited work include:
- Somatic mutations affect key pathways in lung adenocarcinoma (2148 citations)
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers (1884 citations)
- Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer (1125 citations)
What are the main themes of his work throughout his whole career to date?
Jack A. Roth mainly investigates Cancer research, Lung cancer, Internal medicine, Cancer and Surgery.
Jack A. Roth has researched Cancer research in several fields, including Cell culture, Apoptosis, Genetic enhancement, Gene and Tumor suppressor gene.
His research in Cell culture intersects with topics in Molecular biology and Cell.
His Lung cancer study incorporates themes from Immunology, Chemotherapy and Carcinogenesis.
His biological study spans a wide range of topics, including Gastroenterology and Oncology.
His Surgery research includes elements of Respiratory disease, Lung and Esophageal cancer.
He most often published in these fields:
- Cancer research (34.11%)
- Lung cancer (32.71%)
- Internal medicine (23.09%)
What were the highlights of his more recent work (between 2014-2021)?
- Lung cancer (32.71%)
- Internal medicine (23.09%)
- Cancer research (34.11%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Lung cancer, Internal medicine, Cancer research, Oncology and Cancer.
His study focuses on the intersection of Lung cancer and fields such as Surgery with connections in the field of Esophagectomy.
His study in Chemotherapy, Confidence interval, Carcinoma and Neoadjuvant therapy is done as part of Internal medicine.
His Cancer research research integrates issues from Cell, Cancer cell, Immune system, Immunotherapy and non-small cell lung cancer.
He combines subjects such as PD-L1, Targeted therapy, Hazard ratio, Radiation therapy and Cohort with his study of Oncology.
His Cancer study combines topics from a wide range of disciplines, such as Mesothelioma and Gene, Genetic enhancement.
Between 2014 and 2021, his most popular works were:
- Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials (778 citations)
- Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC. (120 citations)
- 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial. (65 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Lung cancer, Internal medicine, Oncology, Cancer research and Cancer are his primary areas of study.
His Lung cancer study combines topics in areas such as Radiation therapy, Surgery, Immunology, Carcinoma and Adenocarcinoma.
The Surgery study combines topics in areas such as Adverse effect and Hazard ratio.
His work carried out in the field of Oncology brings together such families of science as Survival rate, Immune checkpoint inhibitors, Confidence interval, Targeted therapy and Lung.
His Cancer research research is multidisciplinary, relying on both Tumor suppressor gene, Treatment of lung cancer, PI3K/AKT/mTOR pathway and Immune system.
His Cancer research incorporates elements of Mesothelioma and Gene, Genetic enhancement.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
